---
title: "Baylis Medical Technologies announces first commercial use of PowerWire Pro for in-stent restenosis"
date: "2024-06-05T13:10:47.000Z"
publishedDate: "5 juin 2024"
summary: "Baylis Medical Technologies today announced the completion of its first clinical use of the PowerWire Pro radiofrequency (RF) guidewire to safely cross a chronically occluded peripheral stent. The procedure was performed in April 2024 by Mark Iafrati (Vanderbilt University Medical Center, Nashville, USA)."
importance: ""
sourceUrl: "https://vascularnews.com/baylis-medical-technologies-announces-first-commercial-use-of-powerwire-pro-for-in-stent-restenosis/"
tags: ["France", "Actualité", "Vascular News — Latest"]
permalink: "/papers/2024-06-05-baylis-medical-technologies-announces-first-commercial-use-of-powerwire-pro-for-in-stent-restenosis"
imageUrl: "https://vascularnews.com/wp-content/uploads/sites/7/2024/06/PowerwireISR-ConferencePoster-BlueBackground-1-1024x560.png"
imageCredit: "Image de l’article — droits possiblement réservés — https://vascularnews.com/baylis-medical-technologies-announces-first-commercial-use-of-powerwire-pro-for-in-stent-restenosis/"
---

![Baylis Medical Technologies announces first commercial use of PowerWire Pro for in-stent restenosis](https://vascularnews.com/wp-content/uploads/sites/7/2024/06/PowerwireISR-ConferencePoster-BlueBackground-1-1024x560.png)

*Crédit image : Image de l’article — droits possiblement réservés — https://vascularnews.com/baylis-medical-technologies-announces-first-commercial-use-of-powerwire-pro-for-in-stent-restenosis/*

## L’essentiel

Baylis Medical Technologies today announced the completion of its first clinical use of the PowerWire Pro radiofrequency (RF) guidewire to safely cross a chronically occluded peripheral stent. The procedure was performed in April 2024 by Mark Iafrati (Vanderbilt University Medical Center, Nashville, USA).

## Lien source

https://vascularnews.com/baylis-medical-technologies-announces-first-commercial-use-of-powerwire-pro-for-in-stent-restenosis/
